This clinical trial is focused on studying a condition called Chronic Central Serous Chorioretinopathy (cCSC), which affects the eyes and can lead to vision problems. The study will test the effects of a medication called Pred Forte, which is an eye drop containing the active ingredient prednisolone acetate. Prednisolone acetate is a type of steroid that is often used to reduce inflammation. The trial will compare the effects of Pred Forte eye drops with a placebo to see how they affect fluid buildup in the eye, which is a common issue in cCSC.

The purpose of the study is to understand how well Pred Forte works in reducing the fluid in the eye that can cause vision problems in people with cCSC. Participants in the study will use the eye drops for a period of four weeks. During this time, the amount of fluid in their eyes will be measured using a special imaging technique called Optical Coherence Tomography (OCT). This technique helps doctors see detailed images of the eye’s structure and is used to track changes in the fluid levels.

Throughout the study, participants will have their eye health monitored to assess any changes in the fluid levels before and after using the eye drops. The study aims to provide valuable information on whether Pred Forte can be an effective treatment option for managing cCSC and improving vision in affected individuals.